If your Graves' disease is stubborn, you're not alone.

If you’ve been living with Graves’ disease and feel like you’re doing everything right but still struggle to control it, you’re not alone — and it’s not your fault. Graves’ is an autoimmune condition, which means your immune system is driving the problem. And like many autoimmune conditions, it doesn’t always follow a predictable path. 

The truth is, Graves’ disease is harder to manage for some people than others. Understanding the reasons behind this can really help you feel less frustrated and more confident when working with your doctor to develop a plan that’s just right for you. 

First, What Does “Under Control” Even Mean? 

When doctors talk about Graves’ disease going into remission, they mean your thyroid has returned to normal activity and the antibodies that caused the problem have dropped to undetectable levels. That’s the goal with medication. 

But here’s the catch: it takes 12 to 18 months on an antithyroid drug (ATD) just to find out whether remission is possible. And even then, up to 50% of people don’t achieve remission. And among those who do, Graves’ can still come back later in life.  A 2019 study found that 50% of people who stopped taking ATDs had their Graves’ come back within four years. 

 

Did You Know?

There is currently no test that can predict ahead of time whether your Graves’ disease will go into remission. Doctors look at certain clues, but it’s not an exact science, which is why treatment often involves some waiting and watching.

Five Reasons Your Graves’ Disease May Be Harder to Control 

1. Your antibody levels are high — or won’t come down 

Imagine a fire alarm blaring that won’t stop. Your immune system is like a fire alarm that’s stuck in the “on” position. Graves’ disease is driven by antibodies called TSH receptor antibodies (TRAb). The higher your TRAb levels are at diagnosis, the harder it tends to be to achieve remission. TRAb levels are like the alarm — until they quiet down, your body hasn’t gotten the “all clear.” If those levels remain elevated, even after months of treatment, that’s a signal that your immune system is still actively attacking your thyroid. So, remission may be less likely without a change in approach. 

2. Your thyroid is significantly enlarged 

A larger-than-normal thyroid gland, known as a goiter, is linked to lower remission rates when only medication is used. More thyroid tissue means more to treat and more activity to bring under control. 

3. You relapsed after stopping medication 

Some people do well on antithyroid medication but see their Graves’ come back once they stop. This is one of the most common reasons people find themselves back at square one. Research suggests that staying on medication two years or longer — rather than stopping at 12 to 18 months — may improve remission rates for some people. If you’re feeling well on medication, it may be worth talking to your doctor about extending treatment before moving to more definitive options. 

Did You Know?

Methimazole and propylthiouracil (PTU) — the two antithyroid medications used for Graves’ disease — have been available for more than 70 years. They remain effective, but they work by managing the thyroid, not by fixing the underlying autoimmune problem. 

4. You’re unable to tolerate medication 

A small number of people develop serious side effects from antithyroid drugs, including a dangerous drop in infection-fighting white blood cells (called agranulocytosis) or liver problems. If this happens, staying on medication long enough to achieve remission isn’t possible — and moving to a definitive treatment becomes the safer path. 

5. Certain personal factors may play a role 

Research has identified several characteristics that tend to be associated with more difficult-to-control Graves’ disease: 

  • Smoking is linked to more severe Graves’ disease, poorer treatment response, and a higher risk of Graves’ ophthalmopathy (GO) or thyroid eye disease (TED). A recent study (Shahida, 2024) shows smoking triggers Graves’ disease and contributes to TED. 
  • Men with Graves’ disease tend to have lower remission rates with medication than women. 
  • Children and young adults often have more persistent or aggressive disease. 

So, What Are Your Options? 

If medication hasn’t worked — or isn’t working well enough — there are other treatment options that can help to resolve Graves’ disease in the thyroid. Both lead to hypothyroidism (an underactive thyroid), but that’s generally much easier to manage: it’s treated with a simple daily thyroid hormone replacement pill. 

Radioactive iodine (RAI) 

RAI deactivates thyroid cells without surgery. Think of it as removing the thyroid’s ability to overproduce hormone, without going under the knife. It must be given at a full dose to be effective. It may be advised for people who can’t safely have surgery or who react poorly to antithyroid medications. 

A few important things to know: RAI can worsen TED if you have it, so this needs to be discussed carefully with your doctor. It also requires delaying pregnancy for at least one year after treatment. 

Surgery (Thyroidectomy) 

Removing the entire thyroid gland is a quick and permanent solution, often the best choice for fast results. This is especially true if you have severe or difficult-to-stabilize hyperthyroidism, experience certain other complications, or plan to get pregnant soon. Antithyroid medication isn’t safe during pregnancy, so surgery is often preferred for those planning a family. 

The primary risk of thyroidectomy is accidental damage to the parathyroid glands, small glands near the thyroid that help regulate calcium levels in the body. 

New Treatment Possibilities Offer Hope 

For decades, treatment options for Graves’ disease have stayed largely the same. But that is starting to change. Researchers are now developing therapies that target the immune system’s root role in Graves’, not just the thyroid’s response to it. 

One promising area is anti-FcRn therapies, which work by blocking the body’s recycling of the harmful antibodies that drive Graves’ disease. Early clinical trials have shown encouraging results in treatment-resistant patients. 

None of these are widely available yet, but the research pipeline is the most active it’s been in generations. Ask your endocrinologist about clinical trials, or visit ClinicalTrials.gov to learn more about research studies currently underway. 

The Takeaway: Keep the Conversation Going 

Living with hard-to-control Graves’ disease can be exhausting, both physically and emotionally. But having more information about why it’s happening — and knowing that real options exist — can make a real difference. 

No two people with Graves’ disease have the exact same experience. What works for one person may not be the right fit for another. That’s why it’s so important to revisit your treatment plan regularly with your endocrinologist, especially if your symptoms or circumstances change. 

You deserve a plan that works for your life — and the right doctor will help you find it. 

Always talk with your doctor or endocrinologist before making any changes to your treatment plan.

Would You Like More Information Like This?

If you’re interested in receiving more information, resources, and patient-friendly updates about Graves’ disease, we’d love to stay in touch. Leave your email address below to get helpful insights, research updates, and practical tips delivered straight to your inbox.

  • This field is for validation purposes and should be left unchanged.

Track Your Symptoms and Disease Activity

Join CreakyJoints’ patient-centered research registry to track your symptoms, disease activity, and medications — and share with your doctor. Learn more and sign up here.

  • Was This Helpful?